You are viewing: UK Veterinary Contract Manufacturing & Research Market analysis

The UK Veterinary Contract Manufacturing & Research Market was valued at $70.5 Million in 2026 and projected to reach to $99.5 Million by 2031, representing a compound annual growth rate of 7.1%. The UK veterinary contract manufacturing and research market is positioned for steady expansion, supported by the country's established pharmaceutical infrastructure and commitment to animal welfare standards.

UK Veterinary Contract Manufacturing & Research Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Veterinary Contract Manufacturing & Research Market Trends and Insights

  • The UK market benefits from strong regulatory frameworks, advanced research infrastructure, and a robust pharmaceutical and biotechnology sector supporting veterinary innovation.
  • Demand in the UK is driven by increasing investment in animal health solutions, stringent quality standards, and the growing need for specialized contract research organizations serving the veterinary sector. The UK's position as a leading European hub for life sciences research underpins expansion in veterinary contract manufacturing and research services.
  • Between 2026 and 2031, the UK market will be shaped by rising pet ownership, livestock health concerns, and regulatory pressures for safer, more efficacious veterinary products.
  • The UK's established network of contract manufacturers and research institutions positions the country as a key player in meeting European and global demand for outsourced veterinary development and manufacturing capabilities..

Key Market Statistics

  • CAGR (2026-2031) 7.1% CAGR
  • Market Size, 2026 ~USD 70.5 Million
  • Forecast, 2031 ~USD 99.5 Million
  • Country UK

UK Veterinary Contract Manufacturing & Research Market Overview

Market Valuation :

The UK veterinary contract manufacturing and research market is valued at $70.5 million in 2026, with projections reaching $99.5 million by 2031, demonstrating robust growth potential in the region.

Regulatory Excellence :

The UK benefits from stringent regulatory frameworks and compliance standards that drive demand for specialized contract manufacturing services, ensuring high-quality veterinary pharmaceuticals and biologics.

Research Infrastructure :

Advanced research facilities and a strong biotechnology ecosystem in the UK support innovation in veterinary drug development, attracting both domestic and international contract research partnerships.

Growth Trajectory :

With a CAGR of 7.1% from 2026 to 2031, the UK market is outpacing many European counterparts, driven by increasing investment in animal health and pharmaceutical outsourcing trends.

UK Veterinary Contract Manufacturing & Research Market Dynamics

  • The market benefits from increasing outsourcing by UK-based veterinary pharmaceutical companies seeking specialized manufacturing capabilities and cost-efficient research solutions.
  • Growing demand for companion animal therapeutics and livestock health products continues to drive contract manufacturing volumes across the region. Looking ahead, the UK market will be shaped by post-Brexit regulatory developments, increased investment in precision veterinary medicine, and collaboration between academic institutions and commercial entities.
  • The rise of biologics and specialized formulations in veterinary medicine presents significant opportunities for contract manufacturers offering advanced capabilities.
  • Strategic partnerships and capacity expansion initiatives are expected to accelerate market growth through 2031..

Related Ecosystem

Animal Health

Top Technologies
    Top Companies

      Key Takeaways

      • The UK veterinary contract manufacturing and research market is valued at $70.5 million in 2026 and will reach $99.5 million by 2031, growing at a 7.1% CAGR.
      • The UK's advanced regulatory environment and life sciences infrastructure drive demand for specialized contract manufacturing and research services in the veterinary sector.
      • Rising pet ownership and livestock health concerns in the UK are key growth drivers for outsourced veterinary product development and manufacturing.
      • The UK's established network of contract research organizations and manufacturers positions it as a critical hub for European and global veterinary innovation.

      Veterinary Contract Manufacturing & Research Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment CDMO SERVICES (Service)
      Forecast Period 2026–2031
      Growth Rate CAGR of 7.7% from 2026 to 2031
      Largest Segment CDMO SERVICES (Service)
      Market Size Base Year (Billions) ~USD 6.38 (2026)
      Revenue Forecast (Billions) ~USD 9.24 (2031)
      Segments Covered Service, Type

      UK Veterinary Contract Manufacturing & Research Market Report Segmentation

      2 segment dimensions are covered across the global market.

      By Service

      • Cdmo Services
      • Cro Services

      By Type

      • Analytical & Bioanalytical Services And Quality Assurance
      • Discovery & Pre-Clinical Studies
      • Manufacturing
      • Packaging & Labeling
      • Process Api & Formulation Development
      • Quality/Stability & Post-Market Support
      • Regulatory Affairs & Consulting
      • Veterinary Clinical Trials

      UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031

      Segment20242025202620272028202920302031CAGR (%)
      MID-SIZED/SPECIALTY ANIMAL HEALTH FIRMS26.428.330.432.735.137.740.543.67.5
      MULTINATIONAL ANIMAL HEALTH COMPANIES26.62829.631.33334.936.9395.7
      START-UPS & VETERINARY BIOTECH FIRMS8.79.510.511.612.71415.416.910
      TOTAL61.665.970.575.580.886.692.899.57.1

      Target Audience

      • UK Veterinary Pharmaceutical Companies : Manufacturers seeking contract research and outsourced production capabilities need market data to evaluate partnerships, benchmark costs, and identify specialized service providers within the UK ecosystem.
      • Contract Manufacturing Organizations (CMOs) : UK-based and international CMOs require detailed market analysis to assess growth opportunities, competitive positioning, and demand trends for veterinary manufacturing services in Britain.
      • Investment & Private Equity Firms : Investors evaluating opportunities in the UK veterinary healthcare sector need comprehensive market sizing and growth forecasts to support due diligence and portfolio strategy decisions.
      • Research Institutions & Universities : Academic and research organizations in the UK benefit from market insights to identify collaboration opportunities, funding prospects, and commercialization pathways for veterinary research innovations.
      • Business Development & Strategy Teams : Corporate strategists in animal health and pharmaceutical sectors require UK-specific market data to inform expansion plans, partnership strategies, and competitive intelligence initiatives.

      Reasons to Buy this Report

      • UK-Specific Market Intelligence : Gain detailed insights into the UK veterinary contract manufacturing landscape, including market size, growth drivers, and competitive dynamics specific to the British market and regulatory environment.
      • Strategic Investment Planning : Identify high-growth opportunities within the UK market with accurate forecasts through 2031, enabling informed decisions on facility expansion, partnerships, and resource allocation in the region.
      • Regulatory & Compliance Guidance : Understand UK-specific regulatory frameworks, post-Brexit compliance requirements, and quality standards that impact contract manufacturing operations and service delivery in veterinary pharmaceuticals.
      • Competitive Positioning : Benchmark your UK operations against market trends and identify competitive advantages in the 7.1% CAGR growth environment, including emerging service offerings and customer segments.
      • Customer & Partner Identification : Discover key UK-based veterinary pharmaceutical companies, research institutions, and potential partners seeking contract manufacturing and research services in the expanding animal health sector.

      Frequently asked questions

      What is the current size of the UK veterinary contract manufacturing and research market?

      The UK veterinary contract manufacturing and research market is valued at $70.5 million in 2026 and is expected to grow to $99.5 million by 2031.

      What is the growth rate of the UK veterinary contract manufacturing and research market?

      The UK market is projected to grow at a compound annual growth rate (CAGR) of 7.1% from 2026 to 2031.

      What factors are driving growth in the UK veterinary contract manufacturing and research market?

      Key drivers include rising pet ownership, livestock health concerns, stringent regulatory requirements, and increased investment in animal health solutions across the UK.

      Why is the UK important for veterinary contract manufacturing and research?

      The UK is a leading European hub for life sciences with advanced regulatory frameworks, established research infrastructure, and a strong network of contract manufacturers and research organizations serving the veterinary sector.

      What is the forecast market size for the UK veterinary contract manufacturing and research market by 2031?

      The UK veterinary contract manufacturing and research market is forecast to reach $99.5 million by 2031, up from $70.5 million in 2026.

      RESEARCH METHODOLOGY

      This research study extensively utilized both primary and secondary sources. It involved analyzing various factors that influence the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and the strategies employed by key players.

      Secondary Research

      This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary contract manufacturing & research market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments about both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

      Primary Research

      In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development, and operations managers, as well as presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary contract manufacturing & research market. Primary sources from the demand side include R&D scientists and researchers in animal health companies, veterinary clinicians, and veterinary biotech firms developing veterinary therapeutics and technologies.

      Veterinary Contract Manufacturing and Research Market 
 Size, and Share

      Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
      Note 2: Other designations include sales, marketing, and product/service managers.

      Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The total size of the veterinary contract manufacturing & research market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

      Veterinary Contract Manufacturing and Research Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the veterinary contract manufacturing & research market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and obtain precise statistics for all segments and subsegments.

      Market Definition

      The veterinary contract research organization (CRO) market comprises third-party service providers that support animal-health companies in the outsourced research and development of veterinary pharmaceuticals, biologics, vaccines, and related products. Veterinary CROs provide services across the product lifecycle, including discovery support, preclinical studies, target animal safety, clinical field trials, bioequivalence studies, regulatory consulting, and post-approval research, in compliance with veterinary regulatory standards. These services are primarily used by animal-health pharmaceutical companies, biotechnology firms, and vaccine developers to reduce development timelines, access specialized expertise, manage regulatory complexity, and optimize R&D costs without maintaining a complete in-house research infrastructure. The veterinary contract development and manufacturing organization (CDMO) market consists of third-party manufacturers that provide outsourced development, scale-up, and commercial manufacturing services for veterinary drugs, biologics, vaccines, and related products. Veterinary CDMOs support animal-health companies through process and formulation development, API and finished dosage form manufacturing, fill-finish operations, packaging and labeling, quality control, stability testing, and regulatory manufacturing support, operating in accordance with veterinary GMP and biologics regulations.

      These services enable animal-health companies to outsource capital-intensive manufacturing activities, increase production flexibility, manage capacity constraints, and accelerate market entry, particularly for complex formulations, sterile injectables, and veterinary vaccines.

      Key Stakeholders

      • Animal-health pharmaceutical companies
      • Veterinary biotechnology companies
      • Veterinary biologics & vaccine developers
      • Veterinary contract development & manufacturing organizations (CDMOs)
      • Veterinary contract research organizations (CROs)
      • Preclinical & toxicology research laboratories (GLP & non-GLP)
      • Clinical trial management organizations for veterinary studies
      • Regulatory consulting firms specializing in VICH / EMA / FDA-CVM
      • Quality control & analytical testing laboratories (veterinary-focused)
      • Veterinary formulation & process development service providers
      • Packaging, filling, and labeling service providers for veterinary products
      • Animal research facilities & field trial centers
      • Veterinary academic research institutes
      • Livestock research institutions & herd-health trial networks
      • Raw material suppliers for veterinary APIs, excipients, and biologics components

      Report Objectives

      • To define, describe, segment, and forecast the veterinary contract manufacturing & research market by service, product type, animal type, end user, and region
      • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall veterinary contract manufacturing & research market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the veterinary contract manufacturing & research market in five central regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players in the veterinary contract manufacturing & research market and comprehensively analyze their core competencies and market shares
      • To track and analyze competitive developments such as acquisitions, service launches, expansions, collaborations, agreements, and partnerships

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

      Company Information
      • Detailed analysis and profiling of additional market players (up to 5)

      Geographic Analysis

      • Further breakdown of the Rest of Europe veterinary contract manufacturing & research market into Austria, Finland, Switzerland, and other countries
      • Further breakdown of the Rest of Latin American veterinary contract manufacturing & research market into Colombia, Chile, and other countries
      Competitive Landscape Assessment
      • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the veterinary contract manufacturing & research market
      • Competitive leadership mapping for established players in the US

       

      Get the Full Veterinary Contract Manufacturing & Research Market Report

      Full forecast, segment splits, and company analysis for all Veterinary Contract Manufacturing & Research Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status